Sivuyisana ngokufudumeleyo neCandelo lethu leeMveliso zePolypeptide ngokuphumelela ngempumelelo kwi-US FDA yokuhlola indawo "engenaziphene"!

Ukuphumelela uhlolo lwe-FDA kwindawo ene "zero defects" sisiganeko esikhulu kwimbali yethu yophuhliso lwe-cGMP. Akuthethi nje ukuba i-API yethu ifumene ipasipoti yokungena kwimarike yase-US, kodwa iphinda ibonise ukuba ukuphunyezwa kwe-cGMP kwinkampani yethu ngokuthe ngcembe ihambelana nemigangatho yamazwe ngamazwe.